SCHEMBL3555783

SCHEMBL3555783

CC(=O)n1cc(OCCN(C)C)c2cc(Br)cc(Br)c21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 1/20 0.40
KDM4E B2RXH2 7/20 0.39
ALDH1A1 P00352 7/20 0.39
LMNA P02545 2/20 0.39
SMN1; SMN2 Q16637 3/20 0.37
HRH3 Q9Y5N1 5/20 0.36
CYP1A2 P05177 3/20 0.36
CYP2D6 P10635 3/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
TDP1 Q9NUW8 2/20 0.36
ADRA2A P08913 1/20 0.36
PKM P14618 1/20 0.36
ADRA2B P18089 1/20 0.36
ADRA2C P18825 1/20 0.36
ADRA1D P25100 1/20 0.36
HTR2C P28335 1/20 0.36
ADRA1A P35348 1/20 0.36
HRH1 P35367 1/20 0.36
ADRA1B P35368 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3561489 0.88 KDM4E (0.46) HTR7KDM4EALDH1A1LMNASMN1; SMN2
SCHEMBL6920050 0.83 HTR7 (0.45) HTR7KDM4EALDH1A1LMNASMN1; SMN2
SCHEMBL3557948 0.81 ALDH1A1 (0.44) HTR7KDM4EALDH1A1LMNASMN1; SMN2
SCHEMBL3560720 0.78 MAPT (0.41) KDM4EALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL23138186 0.78 CFD (0.36) KDM4EALDH1A1SMN1; SMN2TDP1BLM
SCHEMBL3562851 0.75 KDM4E (0.43) HTR7KDM4EALDH1A1LMNASMN1; SMN2
SCHEMBL3562962 0.74 HTR6 (0.45) HTR7KDM4EALDH1A1LMNASMN1; SMN2
SCHEMBL6820963 0.74 KDM4E (0.46) HTR7KDM4EALDH1A1LMNASMN1; SMN2
SCHEMBL6817310 0.73 HTR7 (0.46) HTR7KDM4EALDH1A1LMNASMN1; SMN2
SCHEMBL14953530 0.73 HTR6 (0.44) HTR7DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567492-B1 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES SUVEN LIFE SCIENCES LTD (IN) 2013-05-22 EP disclosed
US-7718690-B2 N-arylsulfonyl-3-aminoalkoxyindoles RAMAKRISHNA VENKATA SATYA NIROGI 2010-05-18 US disclosed
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles SUVEN LIFE SCIENCES LIMITED (IN) 2009-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles HTR3C, HTR3A, AANAT HTR7 51/4885KDM4E 3751/4885ALDH1A1 1943/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.